StoneX Group Inc. Announces Closing of $550 Million of Senior Secured Notes due 2031
NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) — StoneX Group Inc. (the “Company”; NASDAQ: SNEX), today announced the closing of […]
Magic Empire Global Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Hong Kong, March 01, 2024 (GLOBE NEWSWIRE) — Magic Empire Global Limited (NASDAQ: MEGL) (“MEGL”, or the “Company”) announced that, […]
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024
SOLANA BEACH, Calif., March 01, 2024 (GLOBE NEWSWIRE) — ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global device, cell, […]
Cipher Mining Announces February 2024 Operational Update
NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) — Cipher Mining Inc. (NASDAQ:CIFR) (“Cipher” or the “Company”) today released its unaudited […]
Nasdaq Chief Financial Officer Sarah Youngwood to Present at the Morgan Stanley Technology, Media & Telecom Conference
NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) will be presenting at the following conference with a […]
Silvercrest Asset Management (SAMG) to Announce Fourth Quarter and Year-End 2023 Results and Host Investor Conference Call
NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) — Silvercrest Asset Management Group Inc. (NASDAQ: SAMG) announced today it will host […]
Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
WATERTOWN, Mass., March 01, 2024 (GLOBE NEWSWIRE) — Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology […]
Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
VANCOUVER, Wash., March 01, 2024 (GLOBE NEWSWIRE) — Absci Corporation (Nasdaq: ABSI) (“Absci”), a data-first generative AI drug creation company, […]
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BOSTON, March 01, 2024 (GLOBE NEWSWIRE) — Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care […]
Molecular Partners To Hold Conference Call to Discuss Fourth Quarter and Full Year 2023 Results and Announces Upcoming Investor Presentations
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 01, 2024 (GLOBE NEWSWIRE) — Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech […]
